13G Filing: Tappan Street Partners and Peregrine Pharmaceuticals Inc (PPHM)

Page 3 of 5

Page 3 of 5 – SEC Filing

CUSIP No.

713661502

Page 4 of 7

Item 1(a).		Name of Issuer:	Peregrine Pharmaceuticals, Inc.

Item 1(b).		Address of Issuer’s Principal Executive Offices:	14282 Franklin Avenue, Tustin, California 92780


Item 2(a).		Name of Person Filing: Tappan Street Partners, LLC


Item 2(b).		Address of Principal Business Office or, if None, Residence:
		33 Irving Place, Third Floor, New York, NY 10003


Item 2(c).		Citizenship:
		United States


Item 2(d).		Title of Class of Securities:
		Common Stock, $0.0001 par value per share


Item 2(e).		CUSIP Number: 731661502



Item 3.	If This Statement is Filed Pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

	(a)	☐	Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).

	(b)	☐	Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).

	(c)	☐	Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).

	(d)	☐	Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

	(e)	☒	An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

We may use your email to send marketing emails about our services. Click here to read our privacy policy.

Page 3 of 5